Pureos

Our News

Our companies and we are trying to stay at forefront of innovation with the goal to save and improve patients' lives. We are glad to share our progress on the way to achieving this goal.

January 2021

Narrow River Management announces formation and financing of two new companies developing therapies for renal diseases

January 2021

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

November 2020

AM-Pharma Announces Enrollment of the First Patient in REVIVAL Phase III Pivotal Trial in Patients with Sepsis-Associated Acute Kidney Injury

November 2020

ImCheck Presents at SITC First Clinical Demonstration of Gamma Delta T Cell Activation and Tumor Infiltration with Positive Safety for ICT01

November 2020

Pureos Bioventures invests in seed financing of Corlieve Therapeutics SAS to develop therapies for severe neurological conditions

October 2020

AM-Pharma Appoints Chief Medical Officer and VP Manufacturing to Support Global Pivotal Trial in Sepsis-associated Acute Kidney Injury

October 2020

Araris Biotech Completes CHF 15.2 Million Seed Financing Round

October 2020

ImCheck Announces Four ICT01 Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 35th Annual Meeting

September 2020

Johnson & Johnson Innovation renews its commitment to BaseLaunch Phase II

September 2020

Pureos Bioventures closes first fund with USD 170 mn

September 2020

NovaGo Therapeutics appoints Ian Metcalfe as CEO

September 2020

Pureos invests in EUR 71 million financing of LAVA Therapeutics

September 2020

ImCheck announces investment by BB Pureos Bioventures to close Series B fundraising with total of EUR 54 million

September 2020

ImCheck achieves initial positive independent safety review

July 2020

Pureos invests in EUR 27 million Series A financing of Vico Therapeutics

July 2020

Bridge Biotherapeutics becomes BaseLaunch’s first Asia Pacific partner

July 2020

Covid-19 und die Suche nach dem Schweizer Unicorn. Beitrag mit Dominik Escher auf finews.ch.

June 2020

AM-PHARMA adds regulatory, business development and legal expertise to leadership team

June 2020

BB Pureos Bioventures expands its advisory board by appointing Dr. Omar Khwaja

June 2020

With Roivant Sciences another partner has joined BaseLaunch Phase II

June 2020

BB Pureos Bioventures joins BaseLaunch Phase II as the first venture capital fund

May 2020

"Das Coronavirus wird in der Zivilisation bleiben." Interview mit Klaus Breiner in der Engadiner Post.

April 2020

BB Pureos Bioventures expands its team of Partners and Entrepreneurs with the appointment of Dr. Anja Harmeier

March 2020

AM-Pharma Increases Funding to EUR 163 mn for Phase-III Trial of recAP in SA-AKI

January 2020

Eyevensys Closes USD 30 mn Series B Financing

October 2019

AM-Pharma expands its senior team

August 2019

cnnmoney.ch - Finding the «Sweet Spot» when investing in biotech.

July 2019

AM-Pharma raises EUR 116 mn to conduct pivotal Phase III Trial of recAP in Acute Kidney Injury

April 2019

BB Pureos Bioventures (Pureos) co-led a CHF 12.5 mn investment in Alentis Therapeutics AG

April 2019

European Biotechnology - Alentis Therapeutics debuts with CHF 12.5 mn

April 2019

Basellaunch - Alentis raises 12.5 mn Swiss francs

April 2019

Labiotech.eu - Swiss biotech raises EUR 11 mn to develop treatments fo liver fibrosis

April 2019

Biocentury.com - Why liver disease newco Alentis is aiming for one of largest Swiss A rounds

April 2019

Endpoints News - A biotech fledgling cross-bred in France and Switzerland launches to take on liver problems of global dimensions

March 2019

NovaGo Therapeutics raises CHF 10 mn to develop regenerative anti-Nogo therapy for stroke

September 2018

Finews.ch - Klaus Breiner: 7 Myths about biotech risk capital

June 2018

Hochkarätiger Beirat für neue Risikokapitalgesellschaft BB Pureos Bioventures

June 2018

SRF ECO - Gründer-Schwerpunk mit Fokus auf den Faktor Mensch

May 2018

NZZ.ch - Fünf Fragen an Dominik Escher

April 2018

NZZ.ch - Im Biotech-Sektor klafft eine Finanzierungslücke

February 2018

Handelszeitung.ch - Bellevue Group setzt mit neuem Fonds auf Biotech

February 2018

startupticker.ch - Bellevue Asset Management gründet neue Risikokapitalgesellschaft

February 2018

Finews - Bellevue bids for more risk capital

February 2018

SRF ECO - Pharma-Zwerge: Lukrative Innovation

February 2018

NZZ - Zweierlei Investorenverhalten in der Biotech-Industrie

February 2018

Agéfi - Pureos Bioventures se focalise sur les biotechs actives dans la recherche de médicaments

February 2018

Initative for venture capital in Switzerland